Nuvalent, Inc. (NUVL)
96.43
+1.66
(+1.75%)
USD |
NASDAQ |
Mar 23, 16:00
96.38
-0.05
(-0.05%)
After-Hours: 20:00
Nuvalent Shareholders Equity (Quarterly) : 1.248B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Glaukos Corp. | 656.16M |
| Edgewise Therapeutics, Inc. | 522.26M |
| Cogent Biosciences, Inc. | 636.37M |
| Neurocrine Biosciences, Inc. | 3.253B |
| BioMarin Pharmaceutical, Inc. | 6.087B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.413B |
| Total Liabilities (Quarterly) | 164.37M |
| Current Ratio | 15.27 |